TAK1 is required for survival of mouse fibroblasts treated with TRAIL, and does so by NF-kappaB dependent induction of cFLIPL.
about
Marine Drugs Regulating Apoptosis Induced by Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL)The oncogenic properties of EWS/WT1 of desmoplastic small round cell tumors are unmasked by loss of p53 in murine embryonic fibroblastsGingerol sensitizes TRAIL-induced apoptotic cell death of glioblastoma cellsTransforming growth factor β-activated kinase 1 signaling pathway critically regulates myocardial survival and remodelingTAK1 regulates caspase 8 activation and necroptotic signaling via multiple cell death checkpoints.Non-canonical kinase signaling by the death ligand TRAIL in cancer cells: discord in the death receptor family.Role of the eIF4E binding protein 4E-BP1 in regulation of the sensitivity of human pancreatic cancer cells to TRAIL and celastrol-induced apoptosis.The Impact of the Interferon/TNF-Related Apoptosis-Inducing Ligand Signaling Axis on Disease Progression in Respiratory Viral Infection and Beyond.In mouse embryonic fibroblasts, neither caspase-8 nor cellular FLICE-inhibitory protein (FLIP) is necessary for TNF to activate NF-κB, but caspase-8 is required for TNF to cause cell death, and induction of FLIP by NF-κB is required to prevent it.TRADD is critical for resistance to TRAIL-induced cell death through NF-κB activation.The Autophagy Machinery Controls Cell Death Switching between Apoptosis and Necroptosis.Phosphorylation and polyubiquitination of transforming growth factor beta-activated kinase 1 are necessary for activation of NF-kappaB by the Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor.Human embryonic and induced pluripotent stem cells express TRAIL receptors and can be sensitized to TRAIL-induced apoptosis.LUBAC and ABIN-1 Modulate TRAIL-Based NF-κB Induction in Human Embryonic Kidney 293 Cells.
P2860
Q26859211-FA92AD5A-6A48-4A34-9B46-4897383F28B0Q33642662-1A2C45A8-7BB7-4D0F-820F-8BB846FC9BF1Q34966112-CD97C46E-54F3-45C6-B625-1A56494A6E08Q34995991-1ADD87D8-4C8E-4706-A61E-0F3A93EF788DQ37330927-F5EB7E28-99BA-4DAC-A151-2DB68B745D24Q38098380-5F974881-CA8E-443C-8BD6-FAFDB312CFF1Q39144112-841A3E0E-DF5E-4978-A533-FD0346DF3FFCQ39223220-FAC0E18D-65D6-4E5B-957B-4CA5D1DD697BQ39441125-9BC9D778-B639-47E5-8EC3-6975DBEC31E5Q39533119-3590D410-908A-467E-95C5-8FF1B0D4176BQ39740446-76244740-F08E-4805-BDD4-B6A1EFE7F9A9Q42045465-A0982AE4-2491-4195-8855-81B7B6E09ACDQ42915261-EB93E025-708A-43F9-AD33-FB1CF4C3EDFCQ55076003-4F64CD4E-D620-4016-A180-5433FEE2F12E
P2860
TAK1 is required for survival of mouse fibroblasts treated with TRAIL, and does so by NF-kappaB dependent induction of cFLIPL.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
TAK1 is required for survival ...... dependent induction of cFLIPL.
@ast
TAK1 is required for survival ...... dependent induction of cFLIPL.
@en
TAK1 is required for survival ...... dependent induction of cFLIPL.
@nl
type
label
TAK1 is required for survival ...... dependent induction of cFLIPL.
@ast
TAK1 is required for survival ...... dependent induction of cFLIPL.
@en
TAK1 is required for survival ...... dependent induction of cFLIPL.
@nl
prefLabel
TAK1 is required for survival ...... dependent induction of cFLIPL.
@ast
TAK1 is required for survival ...... dependent induction of cFLIPL.
@en
TAK1 is required for survival ...... dependent induction of cFLIPL.
@nl
P2093
P2860
P50
P1433
P1476
TAK1 is required for survival ...... dependent induction of cFLIPL.
@en
P2093
Bernard Andrew Callus
Donia Moujalled
James Edward Vince
Josep Maria Lluis
Nufail Khan
Ulrich Nachbur
Wendy Diane Cook
Wendy Wei-Lynn Wong
P2860
P356
10.1371/JOURNAL.PONE.0008620
P407
P577
2010-01-08T00:00:00Z